104 related articles for article (PubMed ID: 34444)
1. Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells.
Halle-Pannenko O; Pritchard LL; Motta R; Mathé G
Biomedicine; 1978 Nov; 29(7):253-5. PubMed ID: 34444
[TBL] [Abstract][Full Text] [Related]
2. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Rappaport H
Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
[TBL] [Abstract][Full Text] [Related]
3. Induction and suppression of delayed-type hypersensitivity to non-MHC antigens during lethal graft-versus-host reaction.
Pritchard LL; Huchet R; Bruley-Rosset M; Riché N; Mishal Z; Halle-Pannenko O
J Immunol; 1992 Jul; 149(1):45-52. PubMed ID: 1351502
[TBL] [Abstract][Full Text] [Related]
4. Non-lymphoid thymic components tolerize T cell precursors to all the minor histocompatibility antigens of the thymus-donor strain.
Spach C; Bureaud N; Motta R
Thymus; 1988; 11(1):43-58. PubMed ID: 2964107
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and migration of grafted hemopoietic cells during a graft-versus-host reaction induced by minor non-H-2 histocompatibility antigens in the mouse.
Spach C; Motta R
Biomed Pharmacother; 1985; 39(6):298-309. PubMed ID: 3910129
[TBL] [Abstract][Full Text] [Related]
7. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants.
Meredith RF; Okunewick JP; Raikow RB; Brozovich BJ; Seeman PR; Magliere KC
Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840
[TBL] [Abstract][Full Text] [Related]
8. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
9. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
Holda JH; Maier T; Claman HN
J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
[TBL] [Abstract][Full Text] [Related]
10. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
11. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
Miconnet I; Bruley-Rosset M; Halle-Pannenko O
J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
[TBL] [Abstract][Full Text] [Related]
12. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
Hamilton BL; Bevan MJ; Parkman R
J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
[TBL] [Abstract][Full Text] [Related]
13. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
14. Rat-mouse radiation chimeras: characterization of an antibody-mediated graft-vs-host reaction.
Kateley JR; Gengozian N
J Immunol; 1975 Jan; 114(1 Pt 1):125-32. PubMed ID: 234495
[TBL] [Abstract][Full Text] [Related]
15. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
Budhecha S; Hamilton BL
J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
[TBL] [Abstract][Full Text] [Related]
16. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
Williams FH; Thiele DL
Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
[TBL] [Abstract][Full Text] [Related]
17. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
Maier T; Holda JH; Claman HN
J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
[TBL] [Abstract][Full Text] [Related]
18. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M
Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109
[TBL] [Abstract][Full Text] [Related]
19. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
20. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
